Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • ADBE vs MRNA✓SelectedUSD · MRNAADBE vs MRNA performance historyLatest closeAs of-1.79%11/20
Stock and ETF performance explorer

ADBE vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-67.7%
MRNA return
-27.3%
Excess return
-40.4%
Maximum drawdown
-71.9%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D-1.8%-2.2%+0.4%-1.7%
7D-10.4%-12.7%+2.3%-9.8%
30D-14.6%-20.7%+6.0%-13.8%
3M-20.0%+46.3%-66.3%-22.3%
6M-14.1%+305.2%-319.3%-27.3%
YTD-37.8%+561.2%-599.0%-51.7%
1Y-30.3%+772.1%-802.4%-48.3%
3Y-64.5%+147.0%-211.4%-70.6%
All-67.7%-27.3%-40.4%-69.4%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling